Abstract Library

#2249 Pasireotide as a Possible Tool for the Control of Refractory Hyperinsulinemic Hypoglycemia from Malignant Insulinoma

Introduction: The control of hypoglycemic hyperinsulinemic syndrome from malignant insulinoma is challenging because it is often refractory to diazoxide and somatostatin analogues (SA). Everolimus can have side effects that can limit its use. Pasireotide, a multi-receptor-targeted SA with a high binding affinity to SSTR1 and SSTR5, exhibits a strong inhibitory effect of insulin secretion.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Davi' M

Authors: Zambon G, Cosaro E, Cingarlini S, Trombetta M, Landoni L,

Keywords: pasireotide, malignant insulinoma, hypoglycemia,

#1514 Number and Localization of Positive Lymph Nodes Correlate with Recurrence in Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Implications for Surgery, Staging and Surveillance

Introduction: Lymph Nodes involvement is a powerful prognostic factor for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PNEN)

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Muffatti F

Authors: Muffatti F, Partelli S, Andreasi V, Crippa S, Zamboni G,

Keywords: PNEN, nodes,

#650 Incidental Diagnosis as Prognostic Factor in Different Tumor-Stages of Non-Functioning Pancreatic Endocrine Tumors

Introduction: Although incidental diagnosis of non-functioning pancreatic endocrine tumors (NF-pNETs) is not an assurance of benign behavior, incidental NF-pNETs are associated with improved survival after resection.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Partelli S, Crippa S, Scarpa A, Zamboni G, Falconi M,

Keywords: incidental pancreatic neuroendocrine tumors,